NCT05272475 is a NA clinical trial of Chamomile Tea in Coagulation Disorder, sponsored by Stony Brook University.

Who is sponsoring NCT05272475?

NCT05272475 is sponsored by Stony Brook University.

What drugs are being tested in NCT05272475?

Interventions in NCT05272475: Chamomile Tea, Chamomile Extract Capsule.

What condition does NCT05272475 study?

NCT05272475 studies Coagulation Disorder.

Is NCT05272475 still recruiting?

NCT05272475 is currently completed. Last updated 10 June 2022.

Last reviewed 2022-06-10 · How we verify

NCT05272475

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Acute Effects of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers

Completed NA Last updated 10 June 2022

What this trial tests

NA trial testing Chamomile Tea in Coagulation Disorder in 8 participants. Completed in 12 May 2022.

Timeline

16 March 2022

Primary endpoint
12 May 2022

12 May 2022

Quick facts

Lead sponsor	Stony Brook University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	screening
Enrollment	8
Start date	16 March 2022
Primary completion	12 May 2022
Estimated completion	12 May 2022
Sites	1 location across United States

Drugs / interventions tested

Chamomile Tea — full drug profile →
Chamomile Extract Capsule

Conditions studied

Coagulation Disorder — all drugs for Coagulation Disorder →

Sponsor

Stony Brook University

Who can join

Adults 18 to 75, any sex, with Coagulation Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chamomile may possess anticoagulant effects based on the presence of coumarin-like compounds within the flower. This randomized complete crossover study will investigate the impact of chamomile ingestion acutely on coagulation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Acute Effect of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers: A Randomized Trial.
Kimura R, Schwartz JA, Romeiser JL, Senzel L, et al · · 2024 · cited 1× · PMID 38300838 · DOI 10.1093/jalm/jfad120

Verify or expand the search:

Other trials of Chamomile Tea

Trials testing the same drug.

NCT05006378 — Effect of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers · NA · completed
NCT03526081 — Absorption, Metabolism and Excretion of Apigenin and Apigenin Glycosides · NA · completed

Other recruiting trials for Coagulation Disorder

Currently open trials in the same condition.

NCT06481995 — SWIFT - SWIss Factor XIII Trial in PPH · Phase 4 · recruiting
NCT05139589 — The ENDOCARDITIS AUMC Data Collection · recruiting
NCT05156983 — A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery · Phase 3 · recruiting
NCT05645081 — Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke · recruiting
NCT04524637 — The Utility of Thromboelastography in Traumatic Brain Injury · recruiting

Other Stony Brook University trials

Trials by the same sponsor.

NCT07478250 — First Responder Safety Training (FiRST) · NA · not yet recruiting
NCT07076342 — The Role of mGluR5 in CBT-I · Phase 4 · recruiting
NCT07009691 — Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS · NA · recruiting
NCT07114900 — Randomized Controlled Physical Activity App Intervention for Black Women · Phase 3 · active not recruiting
NCT05245227 — Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05272475 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stony Brook University
Last refreshed: 10 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05272475.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing